| Literature DB >> 28039360 |
Claudia Lentucci1, Anna C Belkina2,3, Carly T Cederquist1, Michelle Chan1, Holly E Johnson1, Sherry Prasad1, Amanda Lopacinski1, Barbara S Nikolajczyk3, Stefano Monti4, Jennifer Snyder-Cappione2,3, Bogdan Tanasa5, M Dafne Cardamone1, Valentina Perissi6.
Abstract
Non-proteolytic ubiquitin signaling mediated by Lys63 ubiquitin chains plays a critical role in multiple pathways that are key to the development and activation of immune cells. Our previous work indicates that GPS2 (G-protein Pathway Suppressor 2) is a multifunctional protein regulating TNFα signaling and lipid metabolism in the adipose tissue through modulation of Lys63 ubiquitination events. However, the full extent of GPS2-mediated regulation of ubiquitination and the underlying molecular mechanisms are unknown. Here, we report that GPS2 is required for restricting the activation of TLR and BCR signaling pathways and the AKT/FOXO1 pathway in immune cells based on direct inhibition of Ubc13 enzymatic activity. Relevance of this regulatory strategy is confirmed in vivo by B cell-targeted deletion of GPS2, resulting in developmental defects at multiple stages of B cell differentiation. Together, these findings reveal that GPS2 genomic and non-genomic functions are critical for the development and cellular homeostasis of B cells.Entities:
Keywords: Notch pathway; development; toll-like receptor (TLR); ubiquitin; ubiquitin-conjugating enzyme (E2 enzyme)
Mesh:
Substances:
Year: 2016 PMID: 28039360 PMCID: PMC5314172 DOI: 10.1074/jbc.M116.755132
Source DB: PubMed Journal: J Biol Chem ISSN: 0021-9258 Impact factor: 5.157